0001877184 2025-05-01 2026-04-30 false 0001877184 DEF 14A KESTRA MEDICAL TECHNOLOGIES, LTD. true <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither our Board nor our compensation committee takes material non-public information</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> into account when determining the timing of equity awards, and we</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> do not time</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the release of material nonpublic information based on equity award grant dates. There were no grants of stock options, stock appreciation rights or similar option-like instruments to our NEOs within four business days before or one business day after the release of material non-public information on Forms 8-K, 10-Q, or 10-K in the fiscal year ended April 30, 2026.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p> false false